The content on this site is intended for healthcare professionals only
Dr Grupp meets with ecancertv at Childhood Cancer 2016 to discuss how engineered T cells are changing therapy of paediatric tumours.
He summarises the development of CAR T cells, and introduces a phase II trial due to report results at ASH 2016.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
ESMO 2024: Latest in EGFR mutated NSCLC
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Uncommon genetic aberrations NTRK, RET, NRG
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert round up July 28th to August 3rd, 2023
